Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure (REMODEL)

This study has been completed.
Sponsor:
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00082589
First received: May 12, 2004
Last updated: May 22, 2008
Last verified: April 2007